Literature DB >> 8133463

Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.

I A de Lannoy1, F Barker, K S Pang.   

Abstract

Single-pass and recirculating rat liver perfusion studies were conducted with [14C]enalapril and [3H]enalaprilat, a precursor-product pair, and the data were modeled according to a physiological model to compare the different biliary clearances for the solely formed metabolite, [14C]enalaprilat, with that of preformed [3H]enalaprilat. With single-pass perfusion, the apparent extraction ratio (or biliary clearance) of formed [14C]enalaprilat was 15-fold the extraction ratio of preformed [3H]enalaprilat, an observation attributed to the presence of a barrier for cellular entry of the metabolite. Upon recirculation of bolus doses of [14C]enalapril and [3H]enalaprilat, the biliary clearance, estimated conventionally as metabolite excretion rate/midtime metabolite concentration, for formed [14C]enalaprilat was again 10- to 15-fold higher than the biliary clearance for preformed [3H]enalaprilat, but this decayed with perfusion time and gradually approached values for preformed [3H]enalaprilat. The decreasing biliary clearance of formed enalaprilat with recirculation was explained by the dual contribution of the circulating and intrahepatic metabolite (formed from circulating drug) to excretion. Physiological modeling predicted (i) an influx barrier (from blood to cell) at the sinusoidal membrane as the rate-limiting process in the overall removal of enalaprilat, (ii) a 15-fold greater extraction ratio or biliary clearance for formed [14C]enalaprilat over [3H]enalaprilat during single-pass perfusion, and (iii) the time-dependent and declining behaviour of the biliary clearance for formed [14C]enalaprilat during recirculation of the medium. In the absence of a direct knowledge of eliminating organs in vivo, this variable pattern for excretory clearance of the formed metabolite within the organ is indicative of a metabolite formation organ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133463     DOI: 10.1007/bf01061689

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  30 in total

1.  Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.

Authors:  I A de Lannoy; R Nespeca; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

2.  Liver circulation and function.

Authors:  R W BRAUER
Journal:  Physiol Rev       Date:  1963-01       Impact factor: 37.312

3.  Effects of perfusate flow rate on measured blood volume, disse space, intracellular water space, and drug extraction in the perfused rat liver preparation: characterization by the multiple indicator dilution technique.

Authors:  K S Pang; W F Lee; W F Cherry; V Yuen; J Accaputo; S Fayz; A J Schwab; C A Goresky
Journal:  J Pharmacokinet Biopharm       Date:  1988-12

4.  Effect of a diffusional barrier to a metabolite across hepatocytes on its kinetics in "enzyme-distributed" models: a computer-aided simulation study.

Authors:  S Miyauchi; Y Sugiyama; H Sato; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

5.  Effect of diffusional barriers on drug and metabolite kinetics.

Authors:  I A de Lannoy; K S Pang
Journal:  Drug Metab Dispos       Date:  1987 Jan-Feb       Impact factor: 3.922

6.  Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.

Authors:  L A Spry; T V Zenser; S M Cohen; B B Davis
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

7.  The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Authors:  D J Tocco; F A deLuna; A E Duncan; T C Vassil; E H Ulm
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

8.  The multiple-indicator dilution technique for characterization of normal and retrograde flow in once-through rat liver perfusions.

Authors:  M V St-Pierre; A J Schwab; C A Goresky; W F Lee; K S Pang
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

9.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

10.  Presence of a diffusional barrier on metabolite kinetics: enalaprilat as a generated versus preformed metabolite.

Authors:  I A de Lannoy; K S Pang
Journal:  Drug Metab Dispos       Date:  1986 Sep-Oct       Impact factor: 3.922

View more
  10 in total

1.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  Species differences in stereoselective hydrolase activity in intestinal mucosa.

Authors:  Y Yoshigae; T Imai; A Horita; H Matsukane; M Otagiri
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.

Authors:  Brian C Ferslew; Kathleen Köck; Arlene S Bridges; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2014-06-23       Impact factor: 3.922

5.  An understanding of flow- and diffusion-limited vs. carrier-mediated hepatic transport: a simulation study.

Authors:  W P Geng; K Poon; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

6.  Organ clearance concepts: new perspectives on old principles.

Authors:  G L Sirianni; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

7.  Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver.

Authors:  Nathan D Pfeifer; Arlene S Bridges; Brian C Ferslew; Rhiannon N Hardwick; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-30       Impact factor: 4.030

8.  Combined recirculation of the rat liver and kidney: studies with enalapril and enalaprilat.

Authors:  I A de Lannoy; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

9.  Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.

Authors:  David G Levitt; Rik C Schoemaker
Journal:  BMC Clin Pharmacol       Date:  2006-01-06

10.  The In Vivo Effect of Transcellular Permeation Enhancers on the Intestinal Permeability of Two Peptide Drugs Enalaprilat and Hexarelin.

Authors:  David Dahlgren; Markus Sjöblom; Mikael Hedeland; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2020-01-26       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.